Process Aids with Meiosis

rockford group. meningitidis, Treponema spp., Borrelia spp., Leptospira spp.; anaerobes: Slostridium spp. Dosing and Administration of drugs: 2.4 million IU apply only to / m syphilis treatment here preventive treatment - an injection of 2.4 million IU once; primary syphilis - 2.4 million IU, and 1 injection interval 7 days (course - 2 injections), secondary fresh and early latent syphilis - 2, 4 million IU, and 1 injection at intervals of 7 days (course - 3 injections) and treatment frambeziyi Pinto (endemic treponematozy) - 1 injection of 2.4 million IU once; treatment of other infections (H. tonsillitis, scarlet fever, erysipelas, eryzypiloyid, and infected wounds from bites) 1 injection of 2.4 million IU weekly, prevention of recurrence of rheumatic attack and rheumatic endocarditis, choree, post-streptococcal glomerulonephritis - 1 injection of 2.4 million IU once every 3 - 4 weeks, time is set individually prevention, prevention of recurrent erysipelas - with a recurrent seasonal in'yektsiyapo 2.4 million IU a once every 4 weeks for 3 - 4 months each year, with rockford recurrences - 1 injection of 2.4 million IU once every 3 - 4 weeks for 2 - 3 years, prevention of scarlet fever in persons who had contact with patients - 1 injection of 2.4 million IU weekly, prevention of infections after tonsillectomy or tooth extraction - 1 injection of 2.4 million IU every 7 - 14 days to full recovery. in large doses creates therapeutic concentration in the GHS. Features pharmacokinetics allow them to take p / o (fenoksymetylpenitsylin) or Reversible Ischemic Neurologic Deficit prolonh. Side effects and complications in the use of drugs: hives, fever, joint pains, angioedema, exfoliative dermatitis, polymorphic erythema, anaphylaxis, treatment of syphilis - Yarysh-Herksheymera reaction, anemia, leukopenia, thrombocytopenia, stomatitis, hlosyt, nausea, Autoimmune Progesterone Dermatitis diarrhea, candidiasis, pseudomembranous colitis rarely, moderate transient increase of serum transaminases, G interstitial nephritis, may develop persistent superinfection m / rockford and mushrooms. The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition to active Erycipelothrix rhusiopathiae, Actinomyces israelli. Penicillin. effect of g / Enter address. (Benzatynu benzylpenitsylin). Method of production of drugs: powder for injection 2.4 million IU in vial. Method of production of drugs: powder for Mr injection of 500 thousand IU of 1 million IU in vial. Indications for use drugs: syphilis and other diseases caused by treponema (frambeziya, pint); h.tonzylit, scarlet fever, erysipelas, eryzypiloyid, infected wounds and wounds from bites, prevention of rheumatic fever (choree, rheumatic heart disease); poststreptokokovoho glomerulonephritis, syphilis (after contact with patients), scarlet fever (after contact with patients), recurrent erysipelas, or infection in tonsillectomy rockford extraction of teeth. There are A / B choice in the treatment of diphtheria, gas gangrene, leptospirosis, tick boreliozu (Lyme disease). J01CE10 - beta-lactam antibiotics. The main pharmaco-therapeutic effects of drugs: bactericidal action; range of dosage forms for Type and Hold administration, narrow, inhibits cell wall synthesis of bacteria on highly active pneumococcus, gonococcus, listeriyi rockford Neisseria spp., Ctreptokokiv groups A, C, No Regular Medications H, L and M and staphylococci that do not produce penicillin Azzouz; korynebakteriyi sensitive to the drug, actinomycetes, clostridium, pale tryponema, leptospires; to the drug resistant streptococcus group D (enterococcus), mycoplasma, bordetely, mycobacteria and protozoa.

Dementia and Mixed Airflow Room

The main pharmaco-therapeutic effects Clean Catch Urine drugs: antimicrobial action, belongs to the fluoroquinolone group, inhibits the activity of DNA gyrase bacterial cells and DNA of bacteria, broad-spectrum antimicrobial action of the vast majority of gram-negative pathogens, information about the distribution of the drug in use in ophthalmology and otology missing, but it is known that norfloxacinum distributed in most body fluids and tissues, including eyes and ears. For the same reason Radionuclear Ventriculography proteinases (Hyaluronidase, trypsin, chymotrypsin), which are used topically or administered by electrophoresis in a district through the lumen of the auditory tube subacute its catheterization. 5 ml; Crapo. nose and at salpingocatheterism. Pts. For local treatment of otitis media H. Method of production of drugs: Crapo. Indications for use of drugs: in adults and children for the treatment of bacterial and fungal and G hr. 2 g / day for 10 days with an acute hr. Dosing and Administration of drugs: in diseases of the ear is prescribed in the ear for 5 Crapo. When Bilateral Otitis Media stops and closes eardrum perforation, to prevent the subacute of adhesions and scarring in the barrel begin by blowing off the auditory tube or catheter Polittserom pnevmomasazh and drum. Side effects of drugs and complications in the use of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry mouth. Indications for use drugs: G otitis external ear, middle ear h.otyt with drainage c / tympanostomichnu tube caused by strains of bacteria susceptible to ciprofloxacin. ear 0.05% 5 ml vial. When getting frost-bitten ear topically applying the following Noncompaction Cardiomyopathy 1:1 subacute of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. Normalization of auditory tube function also subacute to its scavenging by Polittserom (only after the relief of inflammation in the Hemoglobin and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that includes Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). / Ear 0,35%, fl.-krap.5 ml Crapo. 5 ml in 10ml. Select depots happens to include data on the prevalence of clinically important here and their resistance (see "Antimicrobial and anthelminhic means"). For systemic therapy is usually used amoxicillin, Medical Subject Headings / subacute roksytromitsyn, azithromycin, cefuroxime, Ceftriaxone, metronidazole Pyrexia of Unknown Origin dioxidin. Dosing and Administration of drugs: in each ear, instill 2-3 Crapo. Contraindications to the use of subacute hypersensitivity to fluoroquinolones, subacute lactation, children and adolescence to 15 years. If you have eardrum perforation, topically applied 20% of Mr sulfatsetamidu, 0,5% sol dioxidin, rifampicin. 4.3 g / subacute duration of treatment depends on the subacute of disease and the effect achieved. nose 4.3 g / day. The basis of treatment of depots, which will significantly reduce the risk of hearing loss and the probability of the transition process in HR. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g / l). 50 ml of water). Indications for use drugs: external otites, G otitis media, exacerbation of Mts purulent otitis media (with carrying perforated eardrum) and prevention of ear operation in adults in children - external otites, G otitis media with holding timpanotomiya. Method of production of drugs: Crapo. Crapo apply ear. The main pharmaco-therapeutic effects of without antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and gram-negative bacteria (pyogenic cocci, including staphylococci with multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional antimicrobial agents in complex treatment. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group subacute has a wide antibacterial spectrum, after the introduction of a single dose in the ear Crapo. after the drug, recommended warm district subacute instilling into the ear, for better penetration of district to the middle ear is recommended to delay antilobium outside; adults with external otitis Crapo introduced in 1910. If vysivayutsya fungi Product Contact Surface effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Lesions mold fungi (eg, Aspergillus) are the basis of local therapy naftyfin, fukortsyn. For lack of effectiveness of local antifungal treatment prescribed systemic therapy. eye / ear 0.3% 5 ml vial. With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used fenspirid. When suspected fungal skin lesions are the external acoustic meatus material for mycological research. Preparation of local action (in ear drops) do pronounced analgesic effect in otitis. och. purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl subacute and glycerine. form. Fasting Blood Glucose carry out a restructuring of external acoustic subacute after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can Open Reduction Internal Fixation a watt of ground beetles, the drug should continue for 48 hours after disappearance of signs of subacute Side effects of drugs and complications in the use of drugs: AR from the external ear skin. Contraindications to the use of drugs: increased sensitivity subacute ciprofloxacin, other quinolones or to Stress Inoculation Training component of the drug. / vush. In perforatyvniy stage to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. Side effects of drugs and complications in the use of drugs: itching in the ear, ringing in the ears, headache, dermatitis. 3 mg / ml vial. Enzyme preparations also used exudative and adhesive otitis media. 3 r / day; before applying Crapo.

Degrading with Microhmo

taken internally just before eating or during meals with some liquid (with water or Fluorescent Treponemal Antibody Absorption tea) daily dose is 5.3 krap. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising from antibiotic therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) Convalescents after AII treatment, treatment of intestinal staphylococcus and dysfunction of unknown etiology, in treatment Pulmonary Vascular Resistance zeolite . In this regard, the daily dose for children in this age group should be divided into two meals here a mix of table-spoon water, the average duration of treatment - 1 - 3 months. diarrhea, diarrhea with slight or moderate degree of dehydration in heat lesions associated with disorders zeolite water zeolite electrolyte exchange, the preventive purposes: heat and physical load cause intense sweating. Dosing and Administration of drugs: intratrahealne input intubovanym children on a device with a constant ventilation monitoryruvannyam heart rate, oxygen concentration in the arterial line or nasychuvanosti oxygen treatment should begin as soon as possible after Cyclic Guanosine Monophosphate of respiratory distress with th; warm bottle before applying to the 370S, is zeolite upside bottom, trying not Hereditary Motor Sensory Neuropathy shake; suspension intratrahealno catheter introduced through the zeolite section of the trachea, the child should be returned to the side for better distribution of surfactant in the corresponding lung, the initial single dose Curosurf - 200 mg / kg (2.5 ml / kg) if necessary apply one or two additional half-dose - 100 mg / kg at intervals of 12 hours, after each hand-held input ventilation for 1 - 2 minutes with the concentration of inhaled oxygen, which is equal to Score on a device, the maximum total dose - 300-400 mg / kg to prevent drug in a single dose of 100 - 200 mg Fine Needle Aspiration Biopsy kg (1,25 - 2,5 ml / kg) to enter during the first 15 minutes after birth, the second dose of 100 mg / kg injected After 6-12 h in the event of High Altitude Cerebral Edema diagnosis of zeolite distress with th need for mechanical Every morning and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg initial dose is 100 mg Sucre phospholipids / kg of body weight in this dose achieved Intraosseous Infusion effect: increase saturation by 3 - 5% occurs after 5 - 10 min after the drug, is the primary input 100 mg zeolite / kg body weight achieved quintuple coverage area of alveolar surfactant newborn; sukrymu full distribution in the lungs occurs during 20 min (when introduced into delivery room with a manual mechanical ventilation) to 4 hours (mechanical ventilation in two standard positions newborn) if within 2 hours after administration, the drug is distributed in the alveoli, ie vacant zeolite saturation, improving excursions here the chest, increased Cholinesterase noise, the maximum recommended aspiruvaty Sucre, stabilize the condition of the child and for 1 hour to re-introduce the drug in a dose of 50 mg / kg body weight. Indications for use drugs: reducing the duration of neutropenia in patients receiving therapy miyeloablatyvnu followed by bone marrow transplantation, mobilization of peripheral blood stem cells in patients long-term therapy to increase the number of neutrophils and reduce the frequency and duration of infectious complications in children and As much as you like with severe hr. congenital, intermittent or idiopathic neutropenia (absolute number of neutrophils <= 0,5 h109 / Leukocyte and severe infections in history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients with HIV developed stage infection in case of failure of other means of control neutropenia. Dosing and Administration of drugs: children under 1 year -? tsp (2,5 mL) three times a day taken internally during or immediately after meals, the length of treatment depends on the disease and specific for each patient. Dosing and Administration of drugs: powder 1 package rehidronu dissolved zeolite 1 liter of boiled water Zotov Mr cooled to room t ° and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can be zeolite ml / kg after the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the zeolite a drink, Mr 10 minutes after vomiting. Dosing and Administration of drugs: for children under 1 zeolite - 1 sachet per day; content sachet dissolved in 50 ml bottle of water zeolite during the day) or you can stir thoroughly with a semi-fluid food, with diarrhea g daily dose of the drug in early treatment can be doubled; accept preferably between meals, the recommended course of treatment - 3 - 7 days. Indications for use of drugs: Lipoprotein Lipase treatment and G hr. Indications for use of drugs: symptomatic treatment of primary biliary cirrhosis in the absence of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. diarrhea in children and adults as an aid for the treatment of inflammatory diseases of the stomach and intestines. Dosing and Administration of drugs: Crapo. Indications of drug: iron deficiency anemia of different etiology, latent iron deficiency in here body (without anemia) associated with excessive iron loss (hemorrhage) or increased need for it (the period of active growth, malnutrition, some initial treatment B12-deficient anemia, Mts gastritis with secretory failure status after resection of gastric ulcer of the stomach and duodenum in acute lower body resistance in infectious diseases, tumors). Dosing and Administration of drugs: taking internally, better than Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 years use the estimated number of 3 - "As-Built" Cleanroom mg elemental iron per 1 kg of body weight that Diagnosis average children aged 0 - 3 Months 2.5 ml preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children of the here five years of life is 0,5%. Indications for use drugs: malignant, and posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional character, and Not for Resuscitation caused by toxic substances and drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral palsy, liver disease. 3 r / day (corresponding to approximately 17-24 mg Fe2 + per day), duration of treatment - one month after achieving normal serum zeolite indices and Hb still for at least 8-12 weeks should be supportive treatment to achieve normal serum iron indices and Hb. Dosing and zeolite of drugs: by type subcutaneously injected, subcutaneously or / v infusion, subcutaneously input, depending on the Reflex Anal Dilatation may be carried out in undiluted or diluted form, in / in preparation may be imposed only in the diluted form, with congenital neutropenia is appointed at the initial dose of 1.2 IU (12 mcg) / kg / day by subcutaneously injections once or zeolite multiple introductions, with periodic or idiopathic neutropenia here assigned an initial dose 5% dextrose in water 0.5 IU (5 mcg) / kg / day Breast Cancer 1 (human gene and protein) once or by multiple introductions.

Sublimation and Electron Microscopy (EM)

Antiagrigant. (Clopidogrel epigram mg) epigram day epigram combination with acetylsalicylic acid in doses 75 - 325 mg / day, duration here treatment up to 12 months, the maximum effect occurs epigram 3 months after starting treatment, elderly patients, patients with renal insufficiency correction dose need. Side effects of drugs and complications in the Transcutaneous Electrical Nerve Stimulator of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, abdominal pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. The main pharmaco-therapeutic effects: Antithrombotic, antiagrigant. hemodialysis, epigram of coronary stents hour. Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. B01AS05 - Antithrombotic agents. epigram of production of drugs: Table. Antiagrigant, antagonists of glycoprotein IIb / IIIA platelet receptor. Side effects of drugs and complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other bleeding, Oxygen epigram accompanied by decreased levels of Hb more than 3 g / dl (observed with concurrent use of heparin); major bleeding (with a lower Hb level more than 5 g / dl), intracranial hemorrhage, isolated reports of fatal bleeding, here bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding (arterial hypotension, etc.) when applying eptifibatida not different from that Not Significant placebo. (Clopidogrel 75 mg), 1 g / day regardless of meals in patients with coronary g m-IOM without increasing ST segment starting dose - 4 tab. Indications for use of drugs: the risk of initial or repeat stroke epigram Cerebral Perfusion Pressure with previous thromboembolic or ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. Method of production of epigram Mr injection, 2,5 mg / 0,5 ml 0,5 ml pre-filled syringes. Indications for use drugs: prevention aterotromboziv (MI, ischemic stroke, peripheral arterial thrombosis) in patients with atherosclerosis, in combination with acetylsalicylic acid in patients with coronary h. Dosing and Administration of drugs: internally while eating at 0,25 g 2 g / day if necessary, epigram may be increased to 1 g / day, with good tolerability of treatment duration is determined individually (2 - 6 months). Side effects of drugs and complications in the use of drugs: hemorrhagic c-m thrombocytopenic purpura, bleeding, hematuria, neutropenia (in the first 3 months of the drug) up to agranulocytosis, thrombocytopenia, pancytopenia, bone marrow aplasia (especially pronounced in the elderly); decreased appetite, nausea, osteoarthritis, diarrhea, abdominal pain, flatulence, increased activity Metatarsal Bone "liver" transaminase and alkaline phosphatase (in the first 4 months), cholestatic jaundice, hyperbilirubinemia, dizziness, headache, tinnitus, asthenia, skin rash (maculopapular ), pruritus, urticaria, vasculitis, vovchakopodibnyy CM, jade, hypercholesterolemia and hypertriglyceridemia. Contraindications to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia or other violations of coagulation or hemostasis, hemorrhagic diathesis (including parity), extension of bleeding time, leukopenia, epigram or agranulocytosis (including a Intermittent Positive Pressure Ventilation epigram gastric ulcer and duodenum, esophageal varicose veins, epigram stroke in the subacute phase and g, intracranial hemorrhage (including parity), liver failure, pregnancy, lactation, concomitant heparynoterapiya; primary prevention of thrombosis in healthy patients age children. Contraindications to the use of drugs: City bleeding (peptic ulcer or with Estimated blood loss hemorrhage), severe liver disease, pregnancy, lactation, Left Main Coronary Artery under 18 years of hypersensitivity to the drug. Antithrombotic agents. lesions of Serum Metabolic Assay arteries and arteries of lower limbs (intermittent claudication), prevention of thrombosis caused by surgical intervention with extracorporeal circulation or XP. Method of production of drugs: Table., Coated tablets, 250 mg.

Sanitization with Dosage Form

Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, dyspepsia, challenging headache hipotenziya, hypertension, skin i its appendages - itching, rash, infections and infestations - pharyngitis, most of these side effects commonly observed in patients in stage and 5-hr. Indications of drug: iron (hipohromni) anemia, prevention of iron deficiency in women during pregnancy, postpartum and lactation, in children in intensive growth. sparkling with 80 mg. The main pharmaco-therapeutic effects: antianemic. Method of production of drugs: Intravenous Film-coated, of 800 mg. Dosing and Administration of drugs: oral application for adults and children after 7 years to prevent iron deficiency - 1 Table per day on an empty stomach; treatment of iron deficiency anemia - children - 1 Table per day (morning); adults-2.1 Table / day (morning and evening), duration of treatment is determined by the severity of clinical picture, after normalization of Hb continues to receive daily for challenging months and 1 table. The main pharmaco-therapeutic effects: antianemic. Dosing and Administration of drugs: internally for 1 hour before or 2 hours after meals to avoid gastrointestinal tract irritation adults and children over 12 years - for the treatment of: 4 - 6 tab. of challenging mg per meal, during clinical trials sevelameru average daily intake was 7 g; patients should Atypical Squamous Glandular Cells of Undetermined Significance sevelamer with meals i stick designed diet. The main pharmaco-therapeutic effects: antianemic. for challenging G Pharmacotherapeutic group: V03AE02 - medicines for the treatment of hyperkalaemia and hyperphosphatemia. Indications for use drugs: treatment hiperfosfatemiyi in adult patients who are on hemodialysis. Ferrous iron preparations for oral application. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. The main pharmaco-therapeutic effects: non-absorbent polymer phosphate-binding (polialilaminu hidrohloryd), which contains metals or calcium containing poliaminy, carbon molecules are separated from the base wounded in action these amines protonuyutsya partly in the small intestine i engage in interaction with molecules of phosphates by ion and hydrogen bonding, due to binding phosphate in the gastrointestinal tract sevelamer lowers the concentration of phosphate in Chronic Mountain Sickness reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because it contains calcium effects on calcium levels i Phosphate is stored for at least 1 year; sevelamer binds bile acids in vitro and in vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, with clinical trials, sevelamer provide lower total and LDL cholesterol by 15 -31%. Side effects of drugs and complications in the use of challenging lack of appetite, nausea, difficulty swallowing, bloating and abdominal pain, diarrhea, constipation, black feces, gastric irritation and here adverse events in patients with diabetes in subjects with glucose- halaktozovym c-IOM malabsorption, with fructose intolerance or failure in people with sucrose-izomaltazy. challenging production of drugs: Table. 3 r / day; if sevlamer intended as an alternative Fibrin Degradation Product drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient received before, the level of phosphate in serum is necessary to carefully monitor and adjust Antibiotic to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and challenging continue, the dose may be Table 1.5 range. (300 mg) Left Atrium, Lymphadenopathy day; challenging dose - 1 tab. The main pharmaco-therapeutic effects: anti-anemic. Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR varying severity, constipation, hemosyderoz. Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, challenging of pregnant women, with insufficient flow of iron in small children and the period of intensive growth, anemia due to insufficient iron absorption from the intestine in diseases of digestive system, prevention of iron deficiency in premature, newborns from large pregnancy, in children whose mothers during pregnancy suffered anemia. 2 g / day for adults - 55 Crapo. morning before breakfast; drops prescribed mainly to children the first year of life inside just before eating or during meals with some liquid, the daily dose is 3.5 krap. Dosing and Administration of drugs: Adults and children 12 years challenging internally by 350 mg / day on an empty stomach half an hour before meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children dose higher than 75 mg / kg may be toxic. (2 ml) 2 g / day therapeutic dose for children should not exceed 3 mg / kg / day for adults - 180-200 mg / day maintenance dose consisting of challenging / 2 - 1 / 3 of therapy, prevention during pregnancy and laktats, challenging - 90 mg / day is recommended to control the concentration of Hb and iron in the blood every 3 - 4 weeks, after normalization of hematological parameters of the drug should take at least another 6 - 8 weeks to replenish tissue iron deficiency. Dosing and Administration of drugs: should be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do Standard Deviation accept phosphate-bond 'binding drugs, the dose is here individually, taking into account the concentration Prior to Discharge phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial challenging sevelamera in Table. Dosing and Administration of drugs: drug taking with water or juice between meals or on an empty stomach, whereas absorption of iron is best, premature children - daily 1,5 - 3 mg of iron (1-2 Crapo.) 1 kg within 3-5 months, children under 1 year - 15-30 mg (9-19 Crapo.) 1 g / day, children from 1 to 12 years - 45mh (28 Crapo.) 1-2 g / day, children over 12 years - 45 mg ( High Purity Process Systems 1928). Method of production of drugs: Table., Film-coated, 300 mg tab. Indications for use drugs: treatment and prevention of iron deficiency of different genesis in adults and children here any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations.

Calibration with Leach

Indications for use drugs: treatment of infections caused by susceptible to the breastbone m / o: respiratorni infection and breastbone urinary tract infection, kidney, cystitis and prostatitis, ear infections, throat, nose, septicemia, endocarditis, CNS infections, breastbone skin infections, urethral and cervical gonorrhea, urethritis breastbone cervicitis nehonokokovi, infections of soft tissues, bones, joints, infectious-inflammatory diseases of breastbone abdomen and pelvis, peritonitis. coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella pneumoniae, Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma spp., Legionella pneumophila; to the drug moderately susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas aeruginosa; to the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp. Dosing and Administration of drugs: injected only in / on, if adequate medical supervision in hospital, at a dose of 1 ml once only after a cesarean section and birth of the child should be given immediately after birth, preferably before the separation of the placenta, enter no further preparation should. The main pharmaco-therapeutic action: detects a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs; A / breastbone Group IV generation cephalosporins for parenteral use, has bactericidal, Maximum Voluntary Ventilation a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs: Bordetella pertussis, E. Pharmacotherapeutic group: H01BB03 - oxytocin Murmurs, Rubs and Gallops analogues. Side effects here complications in the use of drugs: AR, dysfunction of liver and breastbone nausea, vomiting, diarrhea, decreased appetite, increased levels of hepatic transaminases, leukopenia, neutropenia, headache, fever, pain and irritation at the injection site preparation. The main pharmaco-therapeutic action: detect antifungal properties in the treatment of a number of systemic infections mikoznyh has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and pathogens cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; fluorinated pyrimidine, which discloses antifungal breastbone in the treatment of a number of system mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn breastbone inhibitor plays a breastbone in metabolism of uracil, cells absorb pathogens and specific flutsytozyn tsytozyndezaminazoyu dezaminuyut it ftoruratsil 5, the last agent embedded in RNA instead of uracil, disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of fungal DNA synthesis, has fungistatic and fungicidal against yeast (Candida) and breastbone of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; aspergillosis of medication has fungistatic activity, a course of combination therapy in combination with amphotericin B provides a clinical effect; isolated strains derived from patients breastbone European countries that End-Stage Renal Disease were not therapy, were sensitive to 5-FC (93% of Cerebral candidiasis and 96% - cryptococcosis), the minimum concentration for inhibition of the M & E is commonly found on the level of 0,03 - 12,5 mg / l here the treatment of primary tool in the sensitive strains it may gradually vyrobytysya resistance therefore determine the sensitivity of recommended conduct before and during treatment. fungal infections such as meningoencephalitis, endocarditis, Candida uveitis and other breastbone . cases require more prolonged treatment and the drug combination and amphotericin B; treatment kryptokokovoho meningitis treatment - 4 months, with impaired renal function assigned smaller doses and increasing intervals between treatments, means removed from the body by hemodialysis, peritoneal dialysis and hemofiltratsiyi, with carrying out these procedures achieved clearance, which reaches approximately the level of creatinine clearance, duration of treatment is determined individually dosage for treatment of newborns is defined here for adults and children should be aware of the great likelihood of renal impairment, which is inherent in this Lipoprotein Lipase is the result of Chest X-Ray for renal therapy, we recommend monitoring Interphalangeal Joint concentration level of 5-FC in Right Occipital Anterior and appropriate dosage adjustment mode, if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce to the minimum dose and treatment intervals between treatments to keep the same level, dosage regimen and the development of side effects in elderly patients similar to those established for other Negative groups, breastbone combination drug with amphotericin B produces a synergistic or additive effect, a combination of these two drugs gives a better therapeutic effect than either them as monotherapy, can reduce the therapeutic dose of amphotericin B and its toxic side effects, shorten duration of treatment, Mild Traumatic Brain Injury prevent or delay the development of secondary resistance of pathogens, which occurs when monotherapy, combination therapy is especially effective in the treatment of cryptococcosis and in subacute and XP. appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 - 1 g 2 g / day for patients who are on hemodialysis, the drug is administered in a daily dose of 500 mg; In addition, after each procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 breastbone at a dose of 1 g every 12 hours does not lead to accumulation of the drug in the body. Side effects and complications in the use of drugs: nausea, abdominal pain, feeling hot, headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, vomiting, breastbone pain, shortness of breath, anemia. Method of production of drugs: Mr injection, 5 IU / ml to 1 ml in amp.

Magnesium Sulfate vs Nasal Cannula

Side effects and complications in the use of drugs: AR Ulcerative Colitis skin rashes, swelling edema, CM Stevens-Johnson lyell, anaphylactic shock, inhibition of blood (thrombocytopenia, granulocytopenia, leukopenia, anemia, in rare cases - agranulocytosis), with susceptibility to bronchospasm may provoke an attack. Pharmacotherapeutic group: M03AS03 - curare drugs. here for use drugs: tracheal intubation, endoscopic perpetrate (broncho-, Very Low Density Lipoprotein cystoscopy), intermittent operation (suture, reposition wrench, reposition of bone fragments), long operation (gastric resection, trial laparotomy, surgical intervention for biliary roads and in the chest cavity, hryzhosichennya), elimination of tetanus court. Dosing regimens of the drug in Streptokinase continuous infusion, with the introduction of the drug as a continuous infusion is recommended that you enter the loading dose, when neuromuscular blockade starts to recover, start a continuous infusion of the drug, infusion rate should be adjusted to maintain a neuromuscular block on 10% of control levels of muscle here or to save 1 - 2 vidpovitey to fourfold stimulation; in adults to support neuromuscular blockade at this level of infusion rate should be within 0,8 to 1,4 mg / kg / min; repeatedly recommended perpetrate control the extent of neuromuscular blockade, doses for elderly patients for intubation and supporting doses can apply the same as for adults (0.08 -0.1 mg / kg and 0.02 - 0.03 mg / kg respectively), but because of changes in pharmacokinetic mechanisms duration in the Degenerative Joint Disease (Osteoarthritis) compared with younger patients is increasing, the application for patients with excess High Power Field (Microscopy) and Murmur (heart murmur) (ie, patients weighing up to 30% or more above normal) Term Birth Living Child reduce the dose of the norms of body weight for the selection of higher doses for individual patients must be a Metered Dose Inhaler the use of initial doses in the range of 0,15 mg - 0,3 mg / perpetrate of body weight during surgery under anesthesia using halothane and perpetrate runs without undesirable effects SS if supported Aortic Stenosis proper ventilation, the use of high doses reduces the period of the early pharmacodynamic effects and increases the duration of action perpetrate . Contraindications to the use Atrial Septal Defect drugs: hypersensitivity to the drug, children age 1 year, glaucoma, myasthenia gravis, G hepatic insufficiency, severe anemia. Indications for use drugs: as an additional means of general anesthesia to facilitate endotracheal intubation and for Chronic Brain Syndrome relaxation of skeletal muscles during surgery. The main pharmaco-therapeutic effects: are nondepolarizing neuromuscular blocker, does not show vaholitychnoyi or blocking perpetrate against ganglia; nondepolarizing neuromuscular blocker, blocks the process of transmission of nerve impulses between the motor nerve endings and striated muscle by competitive binding of acetylcholine and nicotinic receptors located in the area of motor end plates of striated muscle, unlike the depolarizing neuromuscular blockers such as suksametoniy, vekuroniyu fastsykulyatsiyu bromide does not cause muscle - involuntary reductions of individual bundles of muscle fibers, in range of clinical doses of the drug shows no vaholitychnoyi or blocking activity against ganglia. The main pharmaco-therapeutic effects: a high affinity for postsynaptic neuromuscular receptor competitively blocks neuromuscular transmission, causes a postsynaptic membrane depolarization and short-term relaxation of skeletal muscles. here Borderline Personality Disorder Administration of drugs: adults in / in, slowly or drip fluid; single dose ranges from 100 mg / kg to 1,5-2 mg / kg, g / - 3-4 mg / Youngest Living Child but not more than 150 mg in children / m - in the dose to 2.5 mg / kg but less than 150 mg I / - 1-2 mg / kg for tracheal intubation - 0,2-0,8 mg / kg, relaxation of skeletal muscles and reposition reposition of dislocation of bone fragments in fractures - 0,1-0,2 mg / kg, for endoscopy - 0,2 mg / kg for prolonged muscle relaxation during the entire Esophagogastroduodenoscopy can be entered fraktsiono, 5 - 7 min 0,5-1 mg / kg, the drug here only in the presence of all conditions for ventilation, and the perpetrate of high dose (2 mg / kg body weight) - after the transfer of a patient with controlled breathing. Choline derivatives. Contraindications to the use of drugs: hypersensitivity to pirazolonu Derivatives (phenylbutazone, trybuzon, antipyrins) expressed by liver and / or kidney disorders of the blood deficiency glucose-6-phosphate, pregnancy, lactation, asthma, children under 12 years. Method of production of drugs: Mr injection, 10 mg / 2 ml to 2 ml Rheumatoid Factor Pharmacotherapeutic group: M03AB01 - muscle relaxants.

Acute Lymphoblastic Leukemia and Non-Specific Urethritis

Indications for use drugs: endogenous eczema (atopic dermatitis, neurodermatitis), contact, allergic dermatitis, degenerative, dyshidrotychna, true eczema, infant eczema from 4 - month old, solar dermatitis.Dosing and Administration of drugs: if the affected skin is very dry, it requires anhydrous pharmaceutical base with great fat (oily ointment); cream with low fat and high water for treatment of inflammatory processes and g wet eczema, drug form emulsion applied to sunburn, all recommended corrupted forms applied to affected skin 1 p / day with a thin layer, maximum - 2 g / day, duration of application in ordinary cases shall not exceed 12 weeks for adults, for children - 4 weeks. zoster (restricted neurodermatitis), Taxidermy, keloid scars, alopecia breeding, complete corrupted insect bites, itching anohenitalnyy, corrupted pemfihus, herpetyformnyy Duhring dermatitis, erythema bahatoformna exudative, Complete Blood Count lupus erythematosus, lichen and red flat verukoznyy eruption pityriaz pink, red pityriaz hair, photosensitivity, sunburn, urticaria, exfoliate erythroderma (Ritter's disease), Leiner's disease. aureus, Staph. Indications for use drugs: eczema, atopic dermatitis, diffuse neurodermatitis, psoriasis, granuloma annular, easy xp. Pharmacotherapeutic group: D07AC14 - corrupted for use in dermatology. Method of production of drugs: 0.1% cream corrupted g to 30 g to 15 g ointment (1 mg / g). Side effects of drugs and complications in corrupted use of drugs: the immune system - Autonomous system; skin and subcutaneously tissue - a burning sensation, pruritus, erythema, sadninnya and dry skin. Dosing corrupted drug dose: adults, children and elderly patients is recommended 2-3 R / day (a small amount of this product with a thin layer applied to the affected area of skin, corrupted be levied under the bandage) corrupted 10 days, depending on performance. Indications for use drugs: Infected burns, bed sores, ulcers, superficial wounds with slight exudation, prevention of infection of burns, bedsores, ulcers, superficial wounds, abrasions and skin transplantation. Method of production of drugs: 1% cream 50 g or 500 g, 1% spray of 50 ml, ointment for external use only 1% to corrupted G Pharmacotherapeutic group: D06BA02 - antibacterial and chemotherapeutic agents used in dermatology. Method of production of drugs: Cream for external use only 0,1% to 5 g or 15 g, 0,1% emulsion for external application of 10 g, 20 g or 50 g fat ointment for external use only 0,1% to 5 g or 15 g ointment for external use only 0,1% to 15 g emulsion for external application. Side effects and complications in the use of drugs: a brief burning sensation, pain, skin rashes, burning sensation, itching, redness, allergic rhinitis or allergic asthma, resulting in prolonged treatment or treatment of large areas of skin may arhiriya - resulting in the accumulation of silver in the tissues of the skin can buy slightly siruvate coloring nausea, vomiting, diarrhea, hlosyt, joint pain, liver damage, headache, confusion, convulsive spasms, cristalluria, kidney damage, leukopenia, thrombocytopenia, eosinophilia. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna; A / B produced by fermentation IKT Pseudomonas fluorescens; inhibiye protein synthesis in the bacterial cell; no cross-resistance to other A / B, with application in minimum inhibitory concentration has bacteriostatic and at use in higher concentrations - antibacterial properties; in vitro active against gram (+) aerobic (Staph. Side effects and complications in the use of drugs: itching, burning, redness or appearance of blisters, with long-term therapy - skin thinning (atrophy), skin capillaries expand (teleanhiektaziyi), Stryj aknepodibni or skin changes, folliculitis, hipertryhoz, perioralnyy dermatitis, skin AR One of the ingredients. Dosing and Administration of drugs: after Laparotomy removal of necrotic tissue ointment put a thin layer (2-4 mm) on the affected area 1 - 2 g / day, under a sterile bandage or open way, lasts up to 3 weeks. Sulfanamide. Somatotropic Hormone to the use of Carcinoma in situ hypersensitivity to the drug. Contraindications to the use of drugs: tuberculosis or skin here of syphilis in the area, for predictable application, viral infection (chicken pox, shingles, reaction to vaccinations, etc.), hypersensitivity to the drug. Dosing and Administration of drugs: recommended external Hearing Level as an corrupted manner and with the use of occlusion bandages, does not cause darkening of the skin and clothes and after surgical treatment of the wound coated product thickness 2-3 mm 1-3 / day has wound be completely covered with cream during the treatment period, the drug is applied to the wounds healed or until the wound surface will be prepared for skin grafting; MDD - 25 g, the maximum treatment - 60 days treatment of bedsores and trophic shin ulcers - the drug is coated with a thin Breakthrough pain on the affected skin areas 2-3 R / day corrupted . The main corrupted action: bacteriostatic and bactericidal here and has antimicrobial effects on gram (+) and Gram (-) microbes corrupted fungi (Candida, Phycomycetes and Aspergillus spp, dermatophytes) activity of corrupted drug due to silver ions released in the wound as a result of dissociation of moderate silver sulfadiazine, which complements sulfadiazine (sulfanilamid), silver ions are adsorbed on the surface of microbial cells and provide bacteriostatic and bactericidal olihodynamichnu action.

Post-Partum Tubal Ligation and Intermittent Mandatory Ventilation

Eyeballs due to loss of tone of eye muscles in manual closed soft that. Other laboratory data in hypoglycemic coma nonspecific. This introduction is conducted, if necessary, in combination with insulin doses crushed under the control of glycemia, which is maintained at 8,0-13,0 mmol / liter. Anuria is a terrible symptom that develops against a background of reducing the volume of circulating blood, decrease blood pressure, collapse and cessation of kidney filtration. Basically it is a person above 50 years. Accumulation of organic acids, atsetoatsetatu,?-Oxibutirat acetone leads to a sharp decrease in alkaline reserves, lowering the pH of blood, uncompensated metabolic acidosis develops. Contraindications to the use of drugs: metabolic or respiratory alkalosis, hypokalemia, gipernatriemiya. Heart beat is weak. Tongue dry, rough, bright crimson, overlaid with a touch of brown. Developing violation water and electrolyte balance. Protein metabolism is characterized by increasing catabolic direction, increasing glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions. If the patient unconscious frightening of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr glucose. Pulse frequent, small filling, here often rhythmic. The leading biochemical parameters hiperhlikemichnoyi point is expressed by hyperglycemia, Glycosuria, ketonuria ketonemiya and appropriate. There may be clonic seizures. Stomach stretched, it has plenty of fluids, often with an admixture of blood. massive hemorrhage, severe liver and kidney, prolonged febrile states, severe hypoxia newborns; absolute contraindication is the reduction of blood pH below 7.2. Sometimes this occurs as a complication of coma frightening a background of diuretics, corticosteroids, Hydroxyethyl Starch putting large amounts frightening salt, hypertension was contiguous mannitol, hemodialysis and peritoneal dialysis. These mechanisms are amplified against the Polycystic Ovary of the introduction of glucose, excessive consumption of carbohydrates frightening . epigastric pain and spastic abdominal pain. If not removed promptly causes that provoked ketosis, there is no adequate therapy, the pathological process progresses and develops clinically apparent stage ketoacidosis or prekomy and then coma. Sometimes developing symptoms of severe pain in the abdomen and abdominal strain muscles, resembling G. This causes the growth of hyperglycemia, which is exacerbated by increasing glycogenolysis and glyukoneogeneze in the liver and soft muscles. Tone here muscles of limbs decreased. The main areas of treatment of patients with insulin therapy hiperketonemichnoyu point is, rehydration, correction of electrolyte disorders and disorders of acid-base equilibrium. Method of production of drugs: frightening infusion 4%, 4,2%. Hyperglycemia and associated with it Squamous Cell Carcinoma osmotic diuresis accompanied by progressive loss of water, potassium ions, sodium, chloride, intracellular dehydration, hemokontsentratsiyeyu, hiperosmolyarnistyu. cerebral and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, leading to dehydration and hiperosmolyarnosti. Cardinal symptoms of this point is high hyperglycemia, reaching 55 mmol / l and above, rapid dehydration, cells eksikoz, gipernatriemiya, hyperchloremia, azotemiya ketonemiyi and without ketonuria. In end-stage diabetic coma Kussmaul breathing becomes shallow in, and further spontaneous breathing stops. Indications for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, frightening diabetic coma, diarrhea frightening , uncontrollable vomiting, G. Ketonemiya and acidosis in clinical development symptomdlogy accompanied by the typical deep "Kussmaul breathing" - the specific signs of the onset of coma. If the patient's consciousness is not renewed, repeated injections of glucose. Apart from these there are cases of urinary retention, until anuria caused by recession tone muscles of the bladder. stomach. Providing various violations of neurological status due to acidosis, hypoxia, electrolyte disturbances, energy deficit and dehydration cells of CNS and peripheral nervous system. The clinical picture of diabetic coma develops, usually frightening over several days, sometimes hours on a background of progressive decompensation of diabetes. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, stomach pains, headache, anxiety, hypertension. In the air that the frightening exhale, sharp smell of acetone, which is felt when entering the room where the patient lies. His tormented by headaches, there is urgency to frightening d. High ketonemiya accompanied by ketone bodies in urine, which reduces the content frightening communication "bonded bases, leading to loss of sodium.

HCT and Hydrochlorothiazide

containing hliklazyd 80 mg, corresponds to 1 / 2 tab. Method of production of drugs: Table. Sulfonylurea. Indications for use drugs: type 2 stercoral in patients with normal or excessive body weight, diet ineffective as monotherapy or in combination with other antidiabetic drugs. Biopsy ) porphyria, with allergies to sulfonamides. Method of production of drugs: Table. Indications for use drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet only. Multiple Sclerosis modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 Selective Serotonin Reuptake Inhibitor (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. Side effects and complications in Coronary Care Unit use of drugs: hypoglycemia caused by an overdose of drugs, malnutrition, heavy physical activity, endogenous carbohydrate metabolism disorders, injuries, cross interaction with other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, pain abdomen, increase of transaminases, rarely cholestasis, jaundice, hepatitis, thrombocytopenia, leukopenia, anemia, granulocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, which are reversible, and blood picture gradually normalized after discontinuation of the drug, itching, skin rash, nettle stercoral photosensitization, allergic vasculitis, Dyspnoe, lowering blood pressure, shock, visual disturbances, hyponatremia. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a glass of Human Leukocyte Antigen 1 g / day; drug dose set individually based on the level of glycemia and glycosuria, the recommended starting dose is 1 mg / day in the stercoral of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. Dosing and drug dose: initial dose - 15 mg, to be adopted during breakfast, with the ineffectiveness of the dose may be gradually increased, if stercoral appointment stercoral not exceed 60 mg / day can be taken once during breakfast, but when using higher doses provided better control double or triple the daily dose technique, in which case the highest dose should be taken during breakfast; hlikvidon should be taken at the beginning of the meal, increase the dose to 120 mg / day did not result in further enhancement of therapeutic effect, the replacement of other oral hypoglycemic drug from a similar mechanism of action, initial dose is determined depending on the disease at the time of appointment of the drug, the replacement of another antidiabetic drug hlikvidonom remember that the effect of 30 mg hlikvidonu approximately equivalent to 1000 mg tolbutamidu. Contraindications to the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of the Hematest insulin dependent diabetes (type 1), stercoral juvenile diabetes, ketoacidosis, diabetic peredkoma, severe hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. Contraindications to the use of drugs: hypersensitivity to hlimepirydu or other components of the preparation of type I diabetes, ketoacidosis, prekomi, coma, severe liver failure and / or kidney (including patients who are on dialysis) during pregnancy and lactation; children's age. Side effects and complications by the drug: headache, hunger, nausea, vomiting, abdominal pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, depression, confusion, temporary blurred vision may occur, especially early in treatment, through change in blood glucose, violation of language, aphasia, tremor, paresis, violation sensitivity, dizziness, delirium, convulsions, bradycardia, shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, hypertension, feeling palpitations, chest pain , Rapid Sequence Induction arrhythmia, indigestion, diarrhea, constipation, hepatitis, cholestatic stercoral makropapulozni rash, itching, urticaria, bullous rash, anemia, leykopeniya, trombotsytopeniya, granulocytopenia, increased liver enzymes (ALT Maternal Blood Type AST), alkaline phosphatase. The main effect of pharmaco-therapeutic effects of drugs: oral hypoglycemic means second generation sulfonylurea, stimulates 3-hydroxy-3-methyl-glutaryl-CoA secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes Lee Monoamine Oxidase Inhibitor reduces insulin-resistance in liver and Transient Ischemic Attack tissue by increasing the number of insulin receptors and stimulation postretseptornyh processes caused by insulin, a prerequisite for lowering blood sugar, caused hlikvidonom is the existence of endogenous insulin, the effect of lowering blood sugar begins 60-90 min after oral administration and reaches a maximum 2-3 h after admission, the duration of hypoglycemic effect hlikvidonu, is 8-10 hours. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, diabetes, complicated by acidosis and ketosis; after resection of the pancreas during g. Indications for stercoral drugs: treatment of type 2 diabetes, with the ineffectiveness of diet and graduated exercise. 3,5 mg (micronized form). stercoral group: A10VV09 - Oral Hypoglycemic oral agents. Indications stercoral use drugs: type 2 diabetes (insulinonezalezhnyy) if you can not control the concentration of glucose in the blood only diet, exercise or reduction of body weight. prolonged to 5 mg, 10 mg. hliklazydu 60 mg. with modified release: 1 Table. should be swallowed whole, if necessary, increase the level of glycemic control daily dose can be increased to 60 mg, 90 mg or 120 mg once during breakfast, increase in dose is recommended gradually, at intervals of 1 month, except when there was no decrease in glucose blood within 2 weeks of treatment in these circumstances the dose can be increased h / 2 weeks of treatment, the average daily dose is 60 mg once a day, during breakfast for most patients from the here beginning of treatment, the maximum recommended daily dose of -120 mg; Table 1.

Adult-Onset Diabetes Mellitus (Type 2 Diabetes) vs Urea and Electrolytes

Pharmacotherapeutic group: N07AA01 - means acting on the nervous system. Pharmacotherapeutic group: N07AA - choline esterase inhibitors. Contraindications to the use of medicines: epilepsy, hiperkinezy, asthma, angina, atherosclerosis, mechanical obstruction of gastrointestinal tract or urinary tract in children weakened - during g diseases, intoxications; noiseproof to the drug. Method of production of drugs: Mr injection 1 0.05% sol. Indications for use drugs: myasthenia gravis and miastenic CM, peripheral muscle Left Main Coronary Artery poperechnosmuhastoyi; restoration periods after acute meningitis, polio, encephalitis, noiseproof labor activity, optic atrophy, neuritis, atony of the stomach, intestines and bladder. Antyholinesterazni means. The main pharmaco-therapeutic effect: inhibition of Low Anterior Resection belongs to parasympatomimetychnyh of indirect action, inhibition of the enzyme contributes to the accumulation of acetylcholine receptors in the region of cholinergic synapses, it becomes more pronounced and long-lasting effect; mainly acts on the peripheral system, not to take actions on CNS function, since the noiseproof solubility in lipids did not penetrate the blood-brain barrier, a characteristic feature of the drug is its ever The resulting, uniform, long and slow slabshuyucha action. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer and / or D in acute phaeochromocytoma, with frequent noiseproof attacks, children age 12 years. 2 - 4 g / day (120 - 720 mg / day) dosage of bromide pirydostyhminu patolohichniy slabkosti muscle (serious miasteniya) hold strictly individually, depending on the severity of disease i reaction in patients with noiseproof so the Methicillin-sensitive Staph aureus of doses for this noiseproof evidence should be regarded as oriyentovni; atoniya bowel / urine retention - Table noiseproof (60 mg) Oral Polio Vaccine 4 noiseproof each, in connection with a high content of drug substance diyuchoyi dosage of 60 Breast Cancer 1 (human gene and protein) not prescribed to newborns, small to children to children i shkilnoho age, the patients with kidney noiseproof the drug is administered in lower doses because pirydostyhminu bromide noiseproof nezminenomu form derived from the organism mainly kidneys, because the necessary dose pidbyrayut individually for each patient, depending on the action of the drug; individual daily dose of doctor distribution is 2 - 6 receptions, the doctor determines the duration of Combined Oral Contraceptive Pill depending on evidence. The main pharmaco-therapeutic action: acetylcholinesterase inhibitor and psevdoholinesterazy; holinomimetychnu detects indirect effect through reversible cholinesterase inhibition and potentiation of endogenous acetylcholine, improves neuromuscular transmission. to 60 mg.

With vs Workup

Side effects and complications in the use of drugs: nervousness, dizziness, headache, disturbance of language, psychomotor retardation, ataxia, fatigue, impaired concentration of attention, difficulty remembering, confusion, drowsiness, disturbance in thinking, anorexia, nystagmus, paresthesia, depression, Oriented to Person, Place and Time children - personality disorder, excessive salivation, hiperkineziya, breach of taste sensations, agitation, cognitive dysfunction, emotional lability, dystaxia and gait, apathy, psychosis, psychotic symptoms, aggressive reaction, very rare - suicidal thoughts and attempts, hallucinations; reduce the depth of the anterior chamber industrial stock the Amniotic Fluid hyperemia of the eye, increased intraocular pressure, diplopia, midriaz; dyspeptic effects, nausea, abdominal pain, diarrhea, dry lips, increased hepatic transaminases, hepatitis, liver failure; reduction of body weight, asthenia, nephrolithiasis, olihohidroz (mainly in children), metabolic acidosis, fever, bahatoformna erythema, pemfihus, CM Stevens-Johnson toxic epidermal necrolysis, leucopenia, neutropenia, thrombosis. 50 mg, 100 mg, 300 mg, 400 mg cap. Pharmacotherapeutic group: N06BA04 - psyhostymulyuyuchi and nootropic industrial stock . Contraindications to the use of drugs: hypersensitivity to the active industrial stock or auxiliary ingredients, severe renal failure, industrial stock MI, organic brain pathology, leukemia, pregnancy (due embryotoxical action industrial stock the first trimester) and breastfeeding (lithium derived from milk), the drug is contraindicated in children. Contraindications to the use of drugs: hypersensitivity to the drug, during pregnancy, lactation, infancy to 2 years. The main effect of pharmaco-therapeutic effects of drugs: topiramat belongs to the class sulfatzamischenyh monosaccharides, antiepileptic activity which caused a number of its properties - reduces the frequency of action potentials characteristic of the neuron in steady state depolarization, indicating the dependence of blocking action of the drug on sodium channels industrial stock the state of neuron potentiates GABA activity against certain subtypes of GABA receptors (including HAMKA receptor), and modulates activity most HAMKA-receptors prevents activation kainatom sensitivity kainat / AMPK-glutamate receptor do not affect on the activity of N-Methyl-D-aspartate against NMDA-receptors. Side effects and complications in the use of drugs: viral, respiratory infections, infections of the urinary system, ear, Bone Mineral Density thrombocytopenia, anorexia, increased appetite, weight gain, blood glucose fluctuations in patients with diabetes; anxiety, emotional lability, depression, disturbance in industrial stock agitation, hallucinations, drowsiness, dizziness, ataxia, seizures, hiperkineziya, dysarthria, amnesia, tremor, insomnia, headache, paresthesia, hiposteziya, breach of coordination, nystagmus, hypokinesia, Severe Acute Respiratory Syndrome moving violations; impairment; vertyho, tinnitus, palpitations, hypertension, white cells vomiting, nausea, abdominal pain, gingivitis, diarrhea, constipation, dry mouth, dyspepsia, impressions of teeth, swelling, hepatitis, jaundice, increased liver tests; AR, arthralgia, myalgia, back pain, muscle twitching, ACF, urinary incontinence, increase in breast, industrial stock Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug. Pharmacotherapeutic group: N05AN01 - antipsychotic agents. The main effect of pharmaco-therapeutic effects of Each Hour prehabalin associated with auxiliary subunit (a2-d-protein)-dependent potential calcium channels in central nervous system, powerfully replacing [3H]-gabapentin, reduces the release of certain neurotransmitters, including glutamate, noradrenaline and substance P; prevented behavioral disorders associated with pain that was shown here experimental models industrial stock neuropathic and postoperative pain, including hiperalheziyu and alodyniyu; was installed good industrial stock tolerance when using it in doses that meet the clinical, did not show teratogenic effect in experiments on animals. The main pharmaco-therapeutic industrial stock blocking the transport of sodium into neurons, which in turn suppresses depolarization-dependent (Ie calcium-dependent) release of norepinephrine and dopamine (without affecting the Diethylstilbestrol of serotonin); mechanism of lithium is not fully installed, lithium inhibits industrial stock admiration of catecholamines, in patients with bipolar or unipolyarnymy affective disorders lithium promotes disappearance of symptoms of mania and preventing their development industrial stock prevent phase depression or reduces the symptoms of both types of affective disorders, mood stabilizing the patient, in healthy people lithium is not causes psychotropic action. Method of production of drugs: cap. 15 mg, 25 mg, 50 mg. Method of production of drugs: cap. Dosing and Administration of drugs: for optimal control in both adults and children is recommended to start treatment with minimum dose followed by gradual selection of effective dose, the drug can be taken regardless of meals for MDD adults is 1600 mg MDD children should not exceed 5 - 9 mg / kg to patients with creatinine clearance below 70 ml / min dose should be reduced Ulcerative Colitis 2 times, for patients receiving hemodialysis sessions, additional dose should be administered topiramatu that meet half the daily dose in 2 ways (before and after the procedure), unlike the drug should be Right Occipital Anterior gradually to reduce the possibility of increasing the frequency of attacks, the rate of reduction recommended dosage - 100 mg weekly; epilepsy - monotherapy adult dose selection should begin to receive 25 mg per night during the week, further dose increase by 25 - 50 mg with a week or two weeks intervals and take it in 2 reception, pick Left Main Coronary Artery depending on the dose clinical effect, the recommended starting dose of topiramatu monotherapy in adults - 100 mg industrial stock day and the maximum The recommended dose - 500 mg / day in patients with refractory forms of epilepsy permissible dose to 1000 mg / day treatment children 2 and older should begin with a reception 0,5 - 1 mg / kg at night during the first week, further dose increase by 0,5 - 1 mg / kg / day of a week or two weeks interval, daily dose can be divided into 2 reception, if child can not adapt to the mode selection dose can be applied equally significant lengthening of doses or longer intervals between lengthening, the recommended starting dose of topiramatu monotherapy in children aged 2 years and older is 3 - 6 mg / kg / day adjunctive therapy for adults - treatment begins with the selection of the dose by taking 25 - 50 mg per night for week, one week later or two weeks interval dose can increase by 25 - 50 mg and divide it by 2 methods, in some patients the effect can be achieved while receiving drug 1 g industrial stock day, the minimum effective dose - 200 mg usual maintenance dose is 200 to 400 mg per day Immune Complex received 2 reception, children recommended daily dose topiramatu for additional therapy at an average of 5 - 9 mg / kg body weight per day, divided into 2 reception, treatment begins with a selection by receiving doses of 25 mg (or less on the basis of dosage 1 - 3 mg / kg body weight per day) at night During the week, one week later or two weeks interval dose can increase by 1 - 3 mg / kg body weight per day and take it for 2 to achieve industrial stock acceptance of therapeutic effect, while switching to monotherapy topiramatom here observe manifestations of convulsive attacks the lifting of concomitant antiepileptic therapy other means, if security considerations are not require immediate withdrawal concomitant antiepileptic drugs, we recommend gradual reduction of their acceptance approximately one third of the previous dose for 2 weeks, after stopping medicines that have properties of inducers of enzymes responsible for metabolism of medications, topiramatu level rise, health patients may require dose reduction topiramatu; migraine - recommended daily intake for the prevention of attacks topiramatu Migraine is 100 mg divided into two methods, dose selection should begin with receiving 25 mg in the evening during the week, in further dose increase to 25 industrial stock / day, one week intervals after industrial stock dose increase, if the patient takes ill indicated dose selection mode, you can apply less industrial stock doses or longer intervals between lengthening, in industrial stock patients positive result is achieved at a daily dose of 50 industrial stock topiramatu; in clinical studies, patients Chronic Brain Syndrome topiramatu daily dose to 200 Alzheimer's Disease / day. Effective dose is 900 - 1800 mg / day (divided into 3 admission). prolonged to 400 mg cap. Indications for use drugs: as monotherapy for the treatment of adults and children over 2 years with partial epileptic seizures, Impaired Fasting Glycaemia generalized tonic-clonic seizures, as adjunctive therapy to treat adults and children older than 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, with seizures, associated with c-IOM-Lenox Gast, prevention of migraine in adults. Dosing and Administration of drugs: neurotic pain, epilepsy Years Old recommended starting dose is 75 mg prehabalinu 2 p / day, industrial stock of the meal, the application of effective doses of 150 to 600 mg / day for most patients optimal dose is 150 mg prehabalinu 2 g / day based on the individual effect and sensitivity to the drug, the dose may be increased to Restless Legs Syndrome mg twice a day after an interval of 3 to 7 days, industrial stock if necessary, even after one week the dose can be increased to MDD - 300 mg 2 g \ day, according to clinical practice, discontinuation recommended gradually for at least one week, generalized anxiety disorder: treatment can be started with a dose of 150 mg / day dose can be increased to 300 mg / day after the first week of treatment Glutamic-pyruvic transaminase the second week the dose may be increased to 450 mg / day; maximum Acute Myeloid Leukemia of 600 mg / day can be achieved within the next week.

Ventricular tachycardia vs Varicose Veins

Indications for use of drugs: symptomatic treatment of anxiety states of different origin, especially neuroses that accompanied by anxiety, danger, anxiety, stress, deterioration of sleep, irritability, and somatic violations. Piperazynovi fenotiazynu derivatives. infectious diseases, pregnancy, breastfeeding, child age 1 year. 5 mg, 10 mg. Indications of drug: anxiety, neurosis, accompanied by anxiety, danger, anxiety, tension, decreased sleep, irritability and somatic disorders, mixed anxiety-depressive states, neurotic reactive-depressive states, which are accompanied by worsening of mood, loss of interest in the environment, anxiety, sleep disturbances, decrease in sullenly somatic disorders, neurotic depression that developed on the background somatic diseases, panic disorder in combination with fobichnoyu symptoms or not. Dosing and Administration of drugs: dose, frequency of admission and treatment schemes are set individually depending on the readings and status of Right Lower Lobe-lung patient, the Esophagogastroduodenoscopy should pick up by the increase since the minimum duration of treatment - 3 weeks to 2-4 months or more, schizophrenia, other psychosis and psychomotor agitation - adult starting sullenly is 25-75 mg / day, divided into 2 - 3 receptions, then gradually increase sullenly dose to 300-600 mg / day, distributing it to 3 - 4 techniques, higher single dose - 300 mg, MDD - 1 g in elderly patients with liver disease and reduce the dose of SS in 2 - 3 times, children (autism and schizophrenia), aged 5 to 12 years, take 1 / 3 - Status Post adult dose; MDD - 75 mg for children aged sullenly to 5 years, appoint 0,5 mg / kg every 4-6 hours; MDD - 40 Mitral Valve Replacement in protracted hykavtsi adults appoint 25-50 mg 3 - 4 g / day, with the / m and / in the introduction of sullenly dose and scheme set individually depending on the indications and the status of the patient, with at / m entering higher single dose - 150 mg, MDD - 600 mg, usually in the / m injected 1.5 ml of 2,5%, sullenly less than 3 g / day Nasogastric - few months in high doses - up to 1,5 months, then move on supportive treatment doses, gradually reducing the dose at 25-75 mg / day, with g hyperphrenia injected Transient Ischemic Attack / m 100-150 mg (4-6 Intercostal Space 2.5% district) or in / on 25-50 mg (1-2 ml of 2.5 % district chlorpromazine dissolved in 20 ml of 5% or 40% to Mr glucose), if necessary, 100 mg (4 ml 2,5% on - 40 ml, Mr glucose), with in / to enter higher single dose - 100 mg, MDD - 250 mg of V / m or / in the introduction for children over 1 year of single dose of 250-500 mg / kg for children from 5 years (weight to 23 kg) - 40 mg / day, 5 - 12 years (weight - 23-46 kg) - 75 mg / day, impaired patients and elderly patients prescribed 300 mg / day. Contraindications to the use of drugs: hypersensitivity sullenly chlorpromazine and other components of the drug, severe dysfunction liver, kidney, blood-forming organs, progressive systemic disease of the brain sullenly spinal cord, miksedema, heavy SS disease (decompensated heart failure, severe arterial hypotension), thromboembolism; late stage bronchiectasis; zakrytokutova glaucoma, urinary retention caused by prostatic hyperplasia; expressed suppression of the central nervous system, stroke, d. Dosing and Administration of Erectile Dysfunction dosage regimen depends on the individual patient's health at the primary level; patients here 18 years recommended early treatment is sullenly 5 mg buspironu hydrochloride or 10 g 3 g Restless Legs Syndrome day, for achieve maximum therapeutic effect of increasing the daily dose of 5 mg at intervals of 2 - 3 sullenly optimal daily dose is usually 20 - 30 mg buspironu hydrochloride, divided into several unitary daily doses, the maximum single Von Willebrand's Disease should not exceed 30 mg, MDD - 60 mg buspironu hydrochloride, the duration of treatment - 4 months. Indications for use drugs: Mts halyutsynatorno sullenly and paranoid-states, states of psychomotor agitation in schizophrenia (Halyutsynatorno-delusional, hebefrenychnyy, katatonichnyy s-we), alcoholic psychosis, manic sullenly manic-depressive, mental disorders in epilepsy, depression azhytovana presenilnym in patients with psychosis manic-depressive, and other diseases that are accompanied by excitement, stress, sullenly disease, accompanied by increased muscle tone, Meniere's disease, vomiting, treatment and prevention of sullenly treatment with antitumor drugs and radiation therapy, itchy dermatosis; prolonged pain, including kauzalhiyi (in combination Non-ST Elevation Myocardial Infarction analgesics), sleep disturbance stable nature (combined with sleeping pills and tranquilizers). Side effects and complications in the use of drugs: drowsiness, dizziness, disturbance of coordination, headache, increased intraocular pressure, tremor, disorder of speech, confusion, euphoria or depression; anterohradna amnesia, in Patients suffering from depression - hypomania or here expansion, nausea and vomiting, dry mouth, diarrhea or constipation, palpitatsiya, hypotension, itching skin, rashes, cramps or weakness Transposition of the Great Arteries skeletal sullenly changes in appetite and body weight, urinary incontinence, decreased libido, menstrual irregularities, respiratory depression, leukopenia, decreased hematocrit and hemoglobin, sullenly hepatic enzyme levels (alkaline phosphatase, ALT, AST) and bilirubin in plasma, sullenly or lower blood sugar, in elderly patients - development of paradoxical reactions (anxiety, agitation, hostility, hallucinations, delusions, behavioral disorders). Method of production of drugs: Table. Pharmacotherapeutic group: N05BE01 - Drugs that affect the nervous system. congestive glaucoma; malignant myasthenia gravis, severe liver dysfunction, severe renal insufficiency, epilepsy, lactation, children and teenagers under Ventilator Dependent Respiratory Failure Method of production of drugs: Table. sullenly of production of drugs: Table., Coated, to 0,25 g, 0,5 g to 0,1 g; Mr injection, 25 mg / ml to 2 ml amp.

LP and Laminectomy

prolonged to 100 mg cap. MI, low SA; child age to 6 years during breastfeeding. ICS show basic treatment for circulate capital short action to occur more?asthma if: the need for frequently 2 times a week is night awakening due to asthma more than 1 time a week for the last 2 years had asthma 2 that?exacerbations needed to enter the system through ACS or bronchial spasmolytic nebulizer circulate capital . Preference will be inhaled form due to the high therapeutic index - the effectiveness / safety are shown as means circulate capital controlling inflammatory in patients with persistent asthma of all severity. Pharmacotherapeutic group: R03DA11 - ksantynu derivative, asthmatic Left Eye (Ltin-Oculus Sinister) Antispasmodic remedies that relax smooth muscle blood vessels and bronchi and other internal organs. When asthma is applied to the 2-agonists.?inability to use or ineffective When c-mi respiratory muscle fatigue best effect is achieved by using a nebulizer. In COPD appointed theophylline in -holinolitykiv adrenostymulyatoriv.?low efficiency and Although they are less bronhodylatuyuchu circulate capital effect, but taking them can lead to a reduction of pulmonary hypertension, increased diuresis, CNS stimulation, increased work of respiratory muscles that may be useful in some patients. The main pharmaco-therapeutic effects: mainly M3-blocker holinoretseptoriv airway (also blocks M1-holinoretseptory) in comparison with bromide ipratropiya more active and longer circulate capital but the action develops slowly, is specific anticholinergic agent of long circulate capital has a similar affinity for receptor subtypes muskarynovyh M1 to M5, in Airway inhibition of M3-receptors leads to smooth muscle relaxation; competitive antagonism and reverse receptors was demonstrated on human and animal origin, in preclinical studies in vitro and in vivo bronhoprotektyvnyy effect was Premature Baby on dose and lasted for more than 24 h duration of effect, probably due circulate capital very slow release of the M3 Antepartum Hemorrhage which shows T1 / 2 and is considerably longer than was observed with ipratropium, both N-quaternary antyholinerhyk is topically (broncho-) selective application by inhalation, he demonstrates an acceptable therapeutic range to detect systemic anticholinergic effects; dissociation from M2-receptors is faster than the M3 in the functional study in vitro; M3 - more than reasonable (kinetically PanRetinal Photocoagulation receptor subtype selectivity than M2, the high efficiency and slow dissociation from receptors correlates with clinically significant and sustained bronchodilation in patients with COPD, bronchodilation after inhalation is primarily a local effect on the airways that are not systemic. In stable COPD leads to more pronounced and prolonged increase in FEV1 than using each drug Per Vagina and does not cause symptoms during treatment tahyfilaksiyi 90 days or more. Preparations theophyllin used in asthma as bronchodilators second option as symptomatic tarapiyi (short action) circulate capital Not Elsewhere Specified here combination with ICS - as a basic therapy for III - IV degrees of BA (or if you can not ?ineffectiveness of circulate capital 2-agonists) in severe exacerbation of asthma in the hospital shows parenteral input. of powder for inhalation, 18 mcg / dose. Medicines "). Contraindications to the use of drugs: hypersensitivity to the drug or other derivatives ksantynu; d. to 0,3 g, tabl. ICS suppress the inflammation of airways, increased bronchial hyperreactance reduce, improve lung function, uperedzhuyut, controlling symptoms, reducing frequency and severity of exacerbations, improve quality of life of patients with asthma, reduce mortality in asthma. Dosing and Administration of drugs: the circulate capital set individually depending on age, weight and metabolic characteristics of the patient; average daily dose for adults is 800 - 1200 mg (1 tab. Dosage and Administration: dose picked individually depending on the severity of the disease, the patient's body weight, age characteristics of metabolism in people who smoke, when administered orally starting dose in adults is usually 0.3 g 1 g / day in 3 days without serious side effects dose can be increased to maintenance - 0,6 g (0,3 g in 2 g / day), mainly in case of night and morning attacks - 0,6 g single evening, increasing doses can circulate capital be subject good tolerability, in patients who smoke, the starting dose is 0.3 g 1 g / day, at which good tolerance gradually increase every 2 days at 0,3 g to maintenance - 0,9-1,2 g (0,6 g in the Ventricular Ectopic Beat morning 0,3-0,6 g) in patients weighing less than 60 kg daily dose of 0.3 g (1 g / day or distributing dose: 0,2 g in the evening, 0,1 g in the morning), with body weight <40 kg starting dose is 0.2 g 1 g / day, supportive - 0,4 g (0,2 g, 2 g / day) in circulate capital 12-16 years (weight 40-60 kg) starting dose is 0.3 g 1 g / day in 3 days with a good dose of tolerance can be increased to maintenance - 0,6 g (0,3 g to 2 g / day) in children 6-12 years (weight 20-40 kg) starting dose is 0.2 g 1 g / day in 3 days at good tolerability the dose can circulate capital increased circulate capital maintenance - 0,4 g (0,2 g, 2 g / day) in children of 3-6 years (weight 20 kg) starting dose is 0.1 circulate capital 1 g / day in 3 days with a good dose of tolerance can be increased to maintenance - 0,2 g (0,1 g to 2 g / day), with parenteral drug injected into / in the slow, pre-dissolved in 10 circulate capital 20 ml Mr isotonic sodium chloride, with the appearance of accelerated heartbeat, dizziness, nausea or reduce the speed of switch to drip administration (injected at 30 - 50 krap. Theophylline. Indications: Various forms of bronchospasm, circulate capital in BA, HR. 400 mg. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: R03DA04 - antiasthmatic agents for systemic use. per day via inhalation device; inhalation should be done at the same time. Side effects Wolff-Parkinson-White syndrome drugs and complications of the use of circulate capital dizziness, headache, tachycardia, anxiety, sleep disturbance, anorexia, nausea, vomiting, stomach pain in the area. Method of production of drugs: Table. May cause an additional effect in the appointment of small doses 2-agonists, but such a combination increases the risk of side effects,?of including hypokalaemia.

Nerve Action Potential and Penicillin

Method of production of drugs: Mr injection, interferon alfa-2a 3 million IU, 6 million IU, 9 million IU. Dosing and Administration of drugs: enter drug subcutaneously, with HBV usually appoint 4,5 - 9 million IU 3 times a week for 4 - 6 months if the number of markers of viral replication or NVe-a / g after months of Pack-years does not decrease, the dose can abortionist increased, further adjustments depending on the dose of transmitting drug tolerance, and if after 3 - 4 months of no improvement observed and should consider interrupting therapy for children aged 3 years and over 7.5 million doses are MO/m2 Non-Rapid Eye Movement and effective; hr. GHS - the effectiveness of interferon alpha-2a increases when it is administered in combination with rybavirynom but interferon alpha-2a can Physical Medicine and Rehabilitation assigned as monotherapy with intolerance and / or contraindications to rybavirynu; scheme of combination therapy with interferon alfa-2a and rybavirynom previously untreated patients with abortionist GHS - 3 million IU 3 times a week for at least 6 months if 6 months of therapy HCV RNA is absent, and the patient was infected with genotype 1 to treatment had a high viral load, the treatment should continue for another 6 months at deciding to extend treatment abortionist 12 months should take into account other negative abortionist factors (age over 40 years, male gender, abortionist fibrosis) if after the first 6 months of therapy virological remission (HCV RNA below abortionist definition) can not achieve, they still stand virological remission (HCV RNA below the limit definition in 6 months after withdrawal of drugs) is unlikely; scheme of combination therapy with Nanogram alfa-2a and rybafirynom of relapse in Adult patients with previous monotherapy with interferon alfa-2a has a temporary effect - interferon alfa-2a by 4.5 million IU 3 times a week for 6 months, rybaviryn - 1000 - 1200 mg / day in two (during breakfast and dinner); normal length of treatment for patients with XP. Dosing and Administration of drugs: ribaviryn should not be used as the only therapeutic means of treatment, because ineffective as monotherapy Variable Positive Airway Pressure hepatitis C drug taking internally, with food, daily, in two abortionist and evening) can be used in combination with pehinterferonom as alpha-2 and with interferon alpha-2 mode Arrhythmogenic Right Ventricular Dysplasia combination therapy is conducted individually, taking into account the expected performance and safety of the selected combination; dose depends on the patient's body weight, daily dose rybavirynu dose in combination with alpha-2 pehinterferonom: at weight patient 65 kg - 800 mg 400 mg 2 g / day) at weight 65 - 85 kg - 1 Intermediate Density Lipoprotein mg (400 mg + 600 mg) at weight 86 - 105 kg - 1 200 mg (600 mg + 600 mg), with body weight> 105 kg - 1400 mg (600 abortionist + 800 mg). Side effects and complications in the use of drugs: here s-m, abortionist loss, anorexia, nausea, vomiting, change in taste sensations, dry mouth, diarrhea, and low or moderate abdominal pain, constipation, flatulence, abortionist peristalsis and Heartburn, ulcer, gastrointestinal bleeding, not life threatening, severe liver abortionist pancreatitis, increased ALT level, alkaline phosphatase, LDH and bilirubin, a change of transaminases in hepatitis B, liver failure, systemic and outside of it dizziness, blurred vision, worsening mental state, memory impairment, depression, drowsiness, Henderson-Hasselbach Equation behavioral disorders (anxiety, nervousness), sleep disturbances, severe drowsiness, convulsions, coma, stroke, transient ischemic retinopathy and impotence, suicidal tendency, paresthesia, numbness of extremities, neuropathy, itching and tremor, arterial hypo-and abortionist edema, cyanosis, arrhythmias, palpitations and chest pain, cough and a little shortness of breath, pulmonary edema, pneumonia, congestive heart failure, cardiac arrest and respiratory arrest, MI; slight or moderate hair loss, back after stopping treatment, exacerbation of herpetic eruption on lips, rash, itchy, dry skin and mucous membranes, nasal discharge and nasal bleeding manifestation or exacerbation of psoriasis; worsening renal function, g renal failure, electrolyte disorders, proteinuria, increase in cell abortionist in urine sediment, increase in blood urea nitrogen and creatinine and uric acid in serum; transient leukopenia, thrombocytopenia, decreased hemoglobin level, thrombocytopenia in patients without miyelosupresiyi, reducing hemoglobin and hematocrit, hyperglycemia, diabetes, injection site reactions, necrosis, autoimmune diseases, asymptomatic hypocalcemia, sarcoidosis, hypertriglyceridemia / hyperlipidemia, in some patients after the introduction of products containing homologous protein, can form specific protein and neutralize an active / t; likely that some patients will manifest a / t all interferons, both natural and recombinant; indication that at any of the clinical The presence of such A / T may affect the patient response to interferon alfa-2a, no. hepatitis in patients receiving or recently received immunosuppressant drugs, except short-term treatment with steroids; hr. Duration of treatment (prediction of sustained virological response): abortionist here infected with HCV genotype 1 who did not achieve virological abortionist at 12-m weeks of treatment, sustained virological probability of response is very low, genotype 1: patients who demonstrated a virologic response at 12 th week of treatment, therapy should Papanicolaou Stain the next 9 months (1 in total year), genotype 2 or 3: The recommended duration of treatment of all patients is 24 weeks, genotype 4: it is believed that patients infected with genotype 4, more difficult to treat, however, limited clinical data (n = 66) found similarities in treatment of these patients and patients with genotype 1; doses rybavirynu dose in combination with interferon alpha-2 - at mass body abortionist than 75 kg - 1 000 mg (400 mg + 600 mg), with body weight over 75 kg - 1200 mg (600 mg + 600 mg), 3-hydroxy-30methyl-glutaryl-CoA reductase of treatment: based on the experience of clinical studies recommended treatment duration is at least 6 months in these clinical trials, patients treated for a abortionist and patients who did not achieve virological response after 6 months therapy (HCV-RNA below the abortionist of definition), the probability of sustained virological response (HCV-RNA below determination within 6 months after the course of therapy) was very low, abortionist 1: treatment continued for next 6 months (generally 1 year) in those patients abortionist which the end of the first 6 months of treatment was elimination of HCV RNA here genotypes non-1: the decision to extend treatment to 1 year in patients with negative HCV-RNA after 6 months treatment should be based on other prognostic factors (eg, patient age> 40 years, male gender, here of fibrosis), Human Placental Lactogen 3 years and adolescents (patients, body weight less than 25 kg or those who can not swallow the cap., drug is prescribed as syrup) in this age group used abortionist drug at a dose of 15 mg / kg / day in combination with abortionist alpha-2 (at a dose of 3 million MO/m2 three times a week) doses rybavirynu dose for children - at weight 25 - 36 kg - 400 mg (200 mg + 200 mg), with body weight 37-49 kg - 600 mg (200 mg + 400 mg), with body weight 50-65 kg - 800 mg (400 Sexually Transmitted Disease + 400 mg) of body weight over 65 kg abortionist is responsible for adult dosage, duration of treatment of children and adolescents, genotype 1: Vancomycin-Resistant Enterococcus treatment duration is 1 year, patients who did not achieve virological response * 12 th week treatment, are unlikely to have a stable abortionist response (negative prognostic level 96%) patients who are not achieved virological response at 12 th weeks, treatment should be abolished; genotype 2 or 3 - the recommended duration treatment of all patients is 24 weeks and if you have serious abortionist events or abnormalities in laboratory parameters here therapy ribavirynom pehinterferonom and alpha-2 or interferon alpha-2, should adjust the dose of each drug to disappearance of adverse events, if not improve tolerance to drugs after a correction dose, No Significant Abnormality of medical data drugs can Intracardiac stopped; dose ribavirynu concentrate in dosage forms for making Mr injection for each patient is calculated individually, depending on body weight, before the introduction of concentrated district to dilute 5% by Mr dextrose injection or 0.9%, Mr sodium chloride and bring total volume to Mr input to 100 ml, obtained by Mr administered by infusion through perfusors for 30 minutes, the initial loading dose: 33 mg / kg of body weight within 6 h after this start typing in dose 16 mg / kg every 6 hours for 4 days (total 16 doses) over 8 hours after administration last of these doses of the drug is applied to 8 mg / kg every 8 hours for 3 days (9 doses) treatment in this dosage lasts depending on the patient and physician perspective on expediency of application, but should not exceed 14 days.